MaaT Pharma:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MaaT Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10977
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota – dysbiosis related diseases. The company focuses on developing MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovative device for stool collection and storage. It also develops therapies based on micro biotherapy and it envisages therapeutic applications for patients with leukemia and bone and joint infections whose treatment contributes to the treatment of dysbiosis. The company also develops treatment for infectious diseases related to onco-hematology in fragile patients. MaaT is headquartered in Lyon, France.

MaaT Pharma – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MaaT Pharma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MaaT Pharma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MaaT Pharma, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
MaaT Pharma Raises USD11 Million in Series A Financing 10
MaaT Pharma Raises USD1 Million in Second Round of Venture Financing 11
MaaT Pharma Raises USD1.2 Million in Seed Financing 12
Partnerships 13
MaaT Pharma Enters into Agreement with Biocodex 13
MaaT Pharma and Bioaster Enter into Co-Development Agreement 14
Licensing Agreements 15
MaaT Pharma Enters into Licensing Agreement with SATT Lutech 15
MaaT Pharma – Key Competitors 16
MaaT Pharma – Key Employees 17
MaaT Pharma – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Clinical Trials 19
Mar 05, 2018: MaaT Pharma Launches European Clinical Trial in Severe Acute Graft-versus-Host Disease for patients receiving allogeneic Hematopoietic Stem Cell Transplantation 19
Jul 20, 2017: MaaT Pharma completes patient recruitment of its Odyssée clinical trial 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
MaaT Pharma, Pharmaceuticals & Healthcare, Key Facts 2
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MaaT Pharma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MaaT Pharma, Deals By Therapy Area, 2012 to YTD 2018 8
MaaT Pharma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MaaT Pharma Raises USD11 Million in Series A Financing 10
MaaT Pharma Raises USD1 Million in Second Round of Venture Financing 11
MaaT Pharma Raises USD1.2 Million in Seed Financing 12
MaaT Pharma Enters into Agreement with Biocodex 13
MaaT Pharma and Bioaster Enter into Co-Development Agreement 14
MaaT Pharma Enters into Licensing Agreement with SATT Lutech 15
MaaT Pharma, Key Competitors 16
MaaT Pharma, Key Employees 17

List of Figures
MaaT Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MaaT Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[MaaT Pharma:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Crane Co:企業の戦略・SWOT・財務分析
    Crane Co - Strategy, SWOT and Corporate Finance Report Summary Crane Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • ZoomMed Inc (ZMD)-医療機器分野:企業M&A・提携分析
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • Essar Power Limited:発電所・企業SWOT分析
    Essar Power Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Internet Initiative Japan Inc (3774):企業の財務・戦略的SWOT分析
    Internet Initiative Japan Inc (3774) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sri Ayudhya Capital Public Company Limited
    Sri Ayudhya Capital Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sri Ayudhya Capital Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Mead Johnson Nutrition Co:企業の戦略的SWOT分析
    Mead Johnson Nutrition Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kuoni Travel Holding Ltd.:企業のM&A・事業提携・投資動向
    Kuoni Travel Holding Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kuoni Travel Holding Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • CIT Group Inc:企業のM&A・事業提携・投資動向
    CIT Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIT Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Innocoll AG (INNL)-医療機器分野:企業M&A・提携分析
    Summary Innocoll AG (Innocoll), formerly Innocoll Holdings Inc is a specialty pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product portfolio includ …
  • Itau Unibanco Holding SA:企業の戦略・SWOT・財務情報
    Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report Summary Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Zoo Digital Group plc (ZOO):企業の財務・戦略的SWOT分析
    Summary Zoo Digital Group Plc (ZOO) is a technology company that offers localization and media production services. The company offers services such as subtitling, captioning, dubbing and digital distribution. Its activities include providing a range of services to allow television and movie content …
  • ADOBE Inc (ADBE):企業の財務・戦略的SWOT分析
    ADOBE Inc (ADBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-psychoactive cannabinoid, formu …
  • Harris Corp (HRS):企業の財務・戦略的SWOT分析
    Harris Corp (HRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Saladax Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, M …
  • Cedars-Sinai Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Cedars-Sinai Medical Center (Cedars-Sinai), formerly Kaspare Cohn Hospital is an academic and medical center that provides healthcare services for patients and medical professionals, and research and education services. The center offers treatments for various conditions such as abdominal pa …
  • Department of Defense Education Activity:企業の戦略的SWOT分析
    Department of Defense Education Activity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Manitou Bf Sa:企業の戦略・SWOT・財務分析
    Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report Summary Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SK Biopharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R …
  • Kobayashi Pharmaceutical Co Ltd (4967):製薬・医療:M&Aディール及び事業提携情報
    Summary Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆